These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26358738)

  • 41. Lectin from Abelmoschus esculentus reduces zymosan-induced temporomandibular joint inflammatory hypernociception in rats via heme oxygenase-1 pathway integrity and tnf-α and il-1β suppression.
    Freitas RS; do Val DR; Fernandes ME; Gomes FI; de Lacerda JT; SantiGadelha T; de Almeida Gadelha CA; de Paulo Teixeira Pinto V; Cristino-Filho G; Pereira KM; de Castro Brito GA; Bezerra MM; Chaves HV
    Int Immunopharmacol; 2016 Sep; 38():313-23. PubMed ID: 27344040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Juniperus rigida Sieb. extract inhibits inflammatory responses via attenuation of TRIF-dependent signaling and inflammasome activation.
    Han JW; Shim DW; Shin WY; Kim MK; Shim EJ; Sun X; Koppula S; Kim TJ; Kang TB; Lee KH
    J Ethnopharmacol; 2016 Aug; 190():91-9. PubMed ID: 27260408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of exercise on inflammation markers in type 2 diabetic subjects.
    Hopps E; Canino B; Caimi G
    Acta Diabetol; 2011 Sep; 48(3):183-9. PubMed ID: 21431832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro.
    Redondo-Castro E; Cunningham C; Miller J; Martuscelli L; Aoulad-Ali S; Rothwell NJ; Kielty CM; Allan SM; Pinteaux E
    Stem Cell Res Ther; 2017 Apr; 8(1):79. PubMed ID: 28412968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential role of salicylates in type 2 diabetes.
    Rumore MM; Kim KS
    Ann Pharmacother; 2010; 44(7-8):1207-21. PubMed ID: 20516365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients.
    Ruscitti P; Cipriani P; Di Benedetto P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Alvaro S; Triolo G; Giacomelli R
    Clin Exp Immunol; 2015 Oct; 182(1):35-44. PubMed ID: 26095630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammation and the etiology of type 2 diabetes.
    Sjöholm A; Nyström T
    Diabetes Metab Res Rev; 2006; 22(1):4-10. PubMed ID: 15991254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel therapeutic approaches in limiting oxidative stress and inflammation.
    Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting inflammation in the treatment of type 2 diabetes.
    Donath MY
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():193-6. PubMed ID: 24003937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-inflammatory and antinociceptive effects of racemic goniothalamin, a styryl lactone.
    Vendramini-Costa DB; Spindola HM; de Mello GC; Antunes E; Pilli RA; de Carvalho JE
    Life Sci; 2015 Oct; 139():83-90. PubMed ID: 26297443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential Effects of Nonsteroidal Anti-Inflammatory Drugs in the Prevention and Treatment of Type 2 Diabetes Mellitus.
    Bellucci PN; González Bagnes MF; Di Girolamo G; González CD
    J Pharm Pract; 2017 Oct; 30(5):549-556. PubMed ID: 27194069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of neuro-inflammatory condition, acetylcholinesterase and antioxidant levels by genistein attenuates diabetes associated cognitive decline in mice.
    Rajput MS; Sarkar PD
    Chem Biol Interact; 2017 Apr; 268():93-102. PubMed ID: 28259689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-inflammatory and anti-nociceptive effect of Betula platyphylla var. japonica in human interleukin-1β-stimulated fibroblast-like synoviocytes and in experimental animal models.
    Huh JE; Hong JM; Baek YH; Lee JD; Choi DY; Park DS
    J Ethnopharmacol; 2011 Apr; 135(1):126-34. PubMed ID: 21396437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of physical activity on mediators of inflammation.
    Nimmo MA; Leggate M; Viana JL; King JA
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():51-60. PubMed ID: 24003921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status.
    Figueras M; Olivan M; Busquets S; López-Soriano FJ; Argilés JM
    Obesity (Silver Spring); 2011 Feb; 19(2):362-9. PubMed ID: 20885391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes.
    Zhang X; Li ZZ; Liu DF; Xu X; Mei ZC; Shen W
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):631-6. PubMed ID: 19076162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.
    Van Linthout S; Riad A; Dhayat N; Spillmann F; Du J; Dhayat S; Westermann D; Hilfiker-Kleiner D; Noutsias M; Laufs U; Schultheiss HP; Tschöpe C
    Diabetologia; 2007 Sep; 50(9):1977-1986. PubMed ID: 17589825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.